Warm-up: setting up a multi-disciplinary tumor board Andriani Charpidou (Athens, Greece)
| |
Advances in TNM staging system Ioannis Gkiozos (Athens, Greece)
| |
Evaluation of the mediastinum EBUS/EUS/mediastinoscopy George Kontopyrgias (Athens, Greece)
| |
Treatment landscape in oncogene driven advanced NSCLC Andriani Charpidou (Athens, Greece)
| |
Clinical impact of immunotherapy in NSCLC treatment landscape Kostas Syrigos (Athens, Greece)
| |
Overview of irAEs Andriani Charpidou (Athens, Greece)
| |
GI toxicity Giorgos Bamias (Athens, Greece)
| |
Endocrinologic toxicity Athina Asimakopoulou (Athens, Greece)
| |
Dermatologic toxicity Vasiliki Nikolaou (Athens, Greece)
| |
Pulmonary toxicity Dimitrios Vassos (Athens, Greece)
| |
Oligometastatic disease Mina Gaga (Athens, Greece)
| |
Immunotherapy in high risk population Evangelia Zampeli (Athens, Greece)
| |
Integrated care approaches in palliative care in thoracic malignancies Georgia Hardavella (London, United Kingdom)
| |
Lung Cancer screening: is there any role for molecular testing Joanna Chorostowska-Wynimko (Warsaw, Poland)
| |
Surgeon perceptive: what is and what is not resectable stage III Levon Toufektzian (Athens, Greece)
| |
Radiation oncology perceptive: radiotherapist considerations for concurrent chemo-RT Zoi Kalaitzi (Athens, Greece)
| |
Thoracic oncologist perceptive: implementing innovation of immunotherapy Andriani Charpidou (Athens, Greece)
| |
The role of surgeon in MPM Levon Toufektzian (Athens, Greece)
| |
Novel targets and emerging therapies in MPM Ioannis Gkiozos (Athens, Greece)
| |
Management of malignant pleural effusions Stamatoula Tsikrika (Athens, Greece)
| |